Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)
Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –
Integra LifeSciences operating margin
Operating margin is operating income as a percentage of revenue.
Integra LifeSciences's operating margin for the twelve months ending Sep 30, 2026 was 4.4%. For fiscal 2025 it was -30.2%, against 1.8% the year before. The highest annual figure on record is 15.3% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -30.2% | −31.9 |
| FY2024 | Dec 31, 2024 | 1.8% | −5.5 |
| FY2023 | Dec 31, 2023 | 7.2% | −8.1 |
| FY2022 | Dec 31, 2022 | 15.3% | +2.6 |
| FY2021 | Dec 31, 2021 | 12.8% | +1.8 |
| FY2020 | Dec 31, 2020 | 11.0% | +4.9 |
| FY2019 | Dec 31, 2019 | 6.2% | −1.4 |
| FY2018 | Dec 31, 2018 | 7.5% | +3.8 |
| FY2017 | Dec 31, 2017 | 3.8% | −7.9 |
| FY2016 | Dec 31, 2016 | 11.6% | +2.6 |
| FY2015 | Dec 31, 2015 | 9.0% | +0.5 |
| FY2014 | Dec 31, 2014 | 8.5% | +3.4 |
| FY2013 | Dec 31, 2013 | 5.1% | −3.8 |
| FY2012 | Dec 31, 2012 | 8.9% | +1.8 |
| FY2011 | Dec 31, 2011 | 7.0% | −6.4 |
| FY2010 | Dec 31, 2010 | 13.5% | −0.9 |
| FY2009 | Dec 31, 2009 | 14.3% | +7.1 |
| FY2008 | Dec 31, 2008 | 7.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 4.6% | +1.7 |
| Q2 FY2026 | Jun 30, 2026 | 4.6% | +128.0 |
| Q1 FY2026 | Mar 31, 2026 | 2.9% | +7.0 |
| Q4 FY2025 | Dec 31, 2025 | 5.3% | −2.8 |
| Q3 FY2025 | Sep 30, 2025 | 2.9% | +5.1 |
| Q2 FY2025 | Jun 30, 2025 | -123.4% | −122.6 |
| Q1 FY2025 | Mar 31, 2025 | -4.0% | −5.1 |
| Q4 FY2024 | Dec 31, 2024 | 8.0% | −1.0 |
| Q3 FY2024 | Sep 30, 2024 | -2.1% | −9.1 |
| Q2 FY2024 | Jun 30, 2024 | -0.7% | −4.0 |
| Q1 FY2024 | Mar 31, 2024 | 1.1% | −8.5 |
| Q4 FY2023 | Dec 31, 2023 | 9.1% | −8.0 |
| Q3 FY2023 | Sep 30, 2023 | 7.0% | −9.9 |
| Q2 FY2023 | Jun 30, 2023 | 3.3% | −11.8 |
| Q1 FY2023 | Mar 31, 2023 | 9.6% | −2.7 |
| Q4 FY2022 | Dec 31, 2022 | 17.0% | +2.7 |
| Q3 FY2022 | Sep 30, 2022 | 16.9% | +2.3 |
| Q2 FY2022 | Jun 30, 2022 | 15.0% | +1.8 |
| Q1 FY2022 | Mar 31, 2022 | 12.3% | +3.7 |
| Q4 FY2021 | Dec 31, 2021 | 14.4% | +0.8 |
| Q3 FY2021 | Sep 30, 2021 | 14.6% | −1.0 |
| Q2 FY2021 | Jun 30, 2021 | 13.3% | +7.9 |
| Q1 FY2021 | Mar 31, 2021 | 8.5% | +0.9 |
| Q4 FY2020 | Dec 31, 2020 | 13.5% | +4.4 |
| Q3 FY2020 | Sep 30, 2020 | 15.5% | +21.0 |
| Q2 FY2020 | Jun 30, 2020 | 5.4% | −6.5 |
| Q1 FY2020 | Mar 31, 2020 | 7.6% | −1.3 |
| Q4 FY2019 | Dec 31, 2019 | 9.1% | +0.2 |
| Q3 FY2019 | Sep 30, 2019 | -5.4% | −11.9 |
| Q2 FY2019 | Jun 30, 2019 | 12.0% | +4.4 |
| Q1 FY2019 | Mar 31, 2019 | 9.0% | +1.8 |
| Q4 FY2018 | Dec 31, 2018 | 8.9% | +6.9 |
| Q3 FY2018 | Sep 30, 2018 | 6.5% | +2.7 |
| Q2 FY2018 | Jun 30, 2018 | 7.5% | +1.5 |
| Q1 FY2018 | Mar 31, 2018 | 7.2% | +3.3 |
| Q4 FY2017 | Dec 31, 2017 | 2.0% | −14.0 |
| Q3 FY2017 | Sep 30, 2017 | 3.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 6.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 3.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 15.9% | – |
See a number that looks wrong?